Abbvie (ABBV) PT Raised to $110 at BofA Securities
Tweet
Share
E-mail
Get Alerts ABBV Hot Sheet
Price: $265.26 +2.45%
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 13
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 13
Join SI Premium – FREE
BofA Securities analyst Geoff Meacham raised the price target on Abbvie (NYSE: ABBV) to $110.00 (from $97.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amer Sports Inc. (AS) PT Lowered to $42 at Truist, but 'Momentum continues to surge in a tough macro'
- Wolfe Research Upgrades Abbvie (ABBV) to Outperform
- Baidu (BIDU) PT Lowered to $150 at Benchmark on Near-Term Margin Concerns
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
